BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12124355)

  • 21. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
    Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
    BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
    Varley CL; Stahlschmidt J; Lee WC; Holder J; Diggle C; Selby PJ; Trejdosiewicz LK; Southgate J
    J Cell Sci; 2004 Apr; 117(Pt 10):2029-36. PubMed ID: 15054105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor-regulated human bladder cancer motility is in part a phosphatidylinositol 3-kinase-mediated process.
    Theodorescu D; Laderoute KR; Gulding KM
    Cell Growth Differ; 1998 Nov; 9(11):919-28. PubMed ID: 9831244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression.
    Manning CB; Cummins AB; Jung MW; Berlanger I; Timblin CR; Palmer C; Taatjes DJ; Hemenway D; Vacek P; Mossman BT
    Cancer Res; 2002 Aug; 62(15):4169-75. PubMed ID: 12154012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.
    Stevenson D; Charalambous C; Wilson JB
    Cancer Res; 2005 Oct; 65(19):8826-35. PubMed ID: 16204053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.
    Dunn SE; Kari FW; French J; Leininger JR; Travlos G; Wilson R; Barrett JC
    Cancer Res; 1997 Nov; 57(21):4667-72. PubMed ID: 9354418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
    Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
    Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.
    Klein RD; Van Pelt CS; Sabichi AL; Dela Cerda J; Fischer SM; Fürstenberger G; Müller-Decker K
    Cancer Res; 2005 Mar; 65(5):1808-13. PubMed ID: 15753378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.
    Mo L; Zheng X; Huang HY; Shapiro E; Lepor H; Cordon-Cardo C; Sun TT; Wu XR
    J Clin Invest; 2007 Feb; 117(2):314-25. PubMed ID: 17256055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment.
    Qu XJ; Yang JL; Russell PJ; Goldstein D
    J Urol; 2004 Aug; 172(2):733-8. PubMed ID: 15247772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro modulation of implantation and intraepithelial expansion of bladder tumor cells by epidermal growth factor.
    Bindels EM; Vermey M; Rebel JM; Zwarthoff EC; Van Der Kwast TH
    Exp Cell Res; 1997 Sep; 235(2):395-402. PubMed ID: 9299164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of Her2/neu overexpression in urothelial carcinomas.
    Alexa A; Baderca F; Zăhoi DE; Lighezan R; Izvernariu D; Raica M
    Rom J Morphol Embryol; 2010; 51(2):277-82. PubMed ID: 20495743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F; Hui YN; Li YJ; Guo CM; Meng H
    Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
    Matsuda K; Idezawa T; You XJ; Kothari NH; Fan H; Korc M
    Cancer Res; 2002 Oct; 62(19):5611-7. PubMed ID: 12359775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
    Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.